Latest News

Two emerging leaders within the Kolling Institute’s Ageing and Pharmacology Lab are gaining attention for their impressive work to improve the quality use of medications. Dr Nashwa Masnoon and Dr Kenji Fujita have received prestigious awards at the annual meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT). Nashwa, who is also a pharmacist at .....
Read more

A special visit by two international cancer specialists could mark the start of a valuable collaborative partnership. Professor Matthew Katz from the MD Anderson Cancer Centre in Houston Texas is recognised as a pioneer in the treatment of pancreatic cancer, while Professor Cynthia Sears from the Johns Hopkins University School of Medicine in Baltimore is a global leader in colorectal cancer resear.....
Read more

An exciting partnership between AGRF Ltd (Australian Genome Research Facility) and the University of Sydney and the Kolling Institute will help strengthen genomic capabilities. The partnership will see a specialised team and cutting-edge technology located within the institute to progress research in this increasingly crucial field. As Australia’s largest provider of genomic services, AGRF supports.....
Read more

The Kolling Institute’s Professor Sue Kurrle and her team at the Rehabilitation and Aged Care Network at Hornsby Ku-ring-gai Hospital have been running clinical trials for 25 years, looking at dementia, frailty, and falls to name just some areas. “We do trials as it keeps you cutting edge and they are really important for our patients,” she says. As a geriatrician on the frontline, Sue is well posi.....
Read more

A $3-million research grant will help develop technology to identify frailty in older people in hospital, a crucial step towards improving care and long-term patient outcomes. The Kolling Institute’s Professor Sarah Hilmer will lead the large-scale study involving hospitals and universities across Australia as well as international investigators. Professor Hilmer said the five-year project will dev.....
Read more

We would like to thank everyone involved in the 2024 Kolling Institute Symposium. During the event, a diverse collection of researchers detailed the latest progress with their ground-breaking work into kidney and heart disease treatments, bone and muscle conditions, rare cancers, and neurological challenges. There was a focus too on the innovative work to develop a unique wellbeing index. Researche.....
Read more

Our Kolling Institute newsletter brings together a collection of profiles on our impressive researchers. Flip through our flipping book to discover more about our leading research into kidney disease, rare cancers and the use of supplements for osteoarthritis. There's a focus too on the first steps towards gene therapy for Meniere's disease, the latest research into treatments for dementia and.....
Read more

After training as a musculoskeletal physiotherapist in India, the Kolling Institute's Dr Saurab Sharma returned to Nepal to treat patients with musculoskeletal pain conditions but quickly found that Western practices to assess and treat pain didn’t translate well to his community. One issue was the internationally-recognised numeric pain rating scale, where zero indicates no pain and 10 is maximum .....
Read more

We would like to congratulate one of our quiet achievers who has taken out a coveted University of Sydney Makers & Shapers award. Executive Dean and Pro Vice-Chancellor Professor Robyn Ward presented Rita leong with her award for her outstanding dedication and support. As the Northern Clinical School’s Corporate Services and Administration Officer, Rita has expertly simplified processes across .....
Read more

Kolling Institute researcher and Royal North Shore Hospital endocrinologist Professor Rory Clifton-Bligh has been involved in clinical trials for more than 20 years, focusing on conditions such as osteoporosis, thyroid cancer and diabetes. Patients in the endocrinology clinic have sometimes accessed medication 10 years ahead of other Australians. Many of these drugs have gone on to be listed on the.....
Read more